Search Results Search Sort by RelevanceMost Recent Case and Commentary Jul 2023 Should Pharmaceuticals Be Used as Weight Loss Interventions for Adolescents Classified as Obese by BMI? Astrid Floegel-Shetty, MA Weight loss is not a safe, effective, or permanent method of health promotion, and pharmacotherapeutical approaches pose specific risks to adolescents. AMA J Ethics. 2023;25(7):E478-495. doi: 10.1001/amajethics.2023.478. State of the Art and Science Mar 2005 HEADSS: The "Review of Systems" for Adolescents Rachel Katzenellenbogen, MD Virtual Mentor. 2005;7(3):231-233. doi: 10.1001/virtualmentor.2005.7.3.cprl1-0503. State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.
Case and Commentary Jul 2023 Should Pharmaceuticals Be Used as Weight Loss Interventions for Adolescents Classified as Obese by BMI? Astrid Floegel-Shetty, MA Weight loss is not a safe, effective, or permanent method of health promotion, and pharmacotherapeutical approaches pose specific risks to adolescents. AMA J Ethics. 2023;25(7):E478-495. doi: 10.1001/amajethics.2023.478.
State of the Art and Science Mar 2005 HEADSS: The "Review of Systems" for Adolescents Rachel Katzenellenbogen, MD Virtual Mentor. 2005;7(3):231-233. doi: 10.1001/virtualmentor.2005.7.3.cprl1-0503.
State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.